 | • レポートコード：MRC2203A136 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の牛健康市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（治療、診断）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の牛健康市場規模：製品種類別（治療、診断） ・世界の牛健康市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Zoetis Inc.、Merck & Co, Inc.、IDVet、…） ・市場機会・将来傾向 |
The market for cattle health is being driven by factors such as increasing R&D expenditure in the cattle health sector, rising initiatives by government, and animal welfare associations and advanced technology leading to innovations in the cattle health sector.
European countries along with the countries in the Asia Pacific are focusing more on the cattle health and implementing several initiatives for the same. For instance, in the United Kingdom, the Cattle Health and Welfare Group (CHAWG) has a crucial role in addressing relevant cattle health and welfare issues. CHAWG is responsible for planning and coordinating a program of economically-focused improvements for cattle health and welfare. CHAWG acts as the first point of call for all cattle health and welfare research, and new disease challenges. Also, countries such as the Netherlands and Germany are having private and public-private partnership insurance schemes are available for cattle, which compensate for consequential losses. In Italy, private insurance schemes are exclusively for dairy production and sheep, but participation is very limited.
Considering the Asia Pacific region, in Australia, the Animal Welfare Task Group developed animal welfare standards and guidelines for cattle and sheep. In addition, an electronic identification system has been developed for the livestock, named national livestock identification system (NLIS), in which, an animal is tagged with a radiofrequency identification device.
Owing to the rising focus on cattle health and involvement of the government, it is expected that the market for cattle health will grow in the coming future.
Key Market Trends
Vaccines are Expected Dominate the Therapeutics Segment Over the Forecast Period.
Vaccination of the beef cattle herds is designed to protect the cattle from different kinds of microorganisms, such as viruses, bacteria, and protozoans. Most of the vaccines used for cattle are injectables. However, some of the vaccines are given by intranasal or oral route.
The vaccines used for cattle health include modified live organisms, killed or chemically altered organisms. With the right use of the vaccine, cattle’s resistance toward the disease may be increased, irrespective of the type of vaccine used. The modified live vaccines contain little amount of viruses or bacteria, which are used for the single-dose purpose and may not develop allergic reactions in the cattle.
The killed vaccines or toxoids are available for various types of disease and are likely to cause allergic reactions. The chemically altered vaccines show similar results like the modified live vaccines. The rising cattle population, increasing R&D expenditure and latest technologies are helping the vaccine segment to expand its reach. The market is inclusive of different kind of vaccines, such as vaccination for respiratory diseases, clostridial vaccines, botulism vaccine, and vaccination for diseases that cause infertility or abortion in the cattle. In addition to the above-mentioned list, vaccines are also available for some of the specific diseases, such as bovine ephemeral fever, anthrax, tick fever, etc.
The availability of such vaccines is the result of R&D efforts taken by the companies and the increasing awareness among people about cattle health.
North America Dominates the Market
North America is believed to dominate the market due to increasing R&D expenditure in cattle health and advanced technology leading to innovations in the cattle health sector in this country, which, in turn, helps in the growth of this market.
Due to the huge demand for dairy products in the United States, there is a huge requirement of cattle population. Cattle health products are very important for maintaining cattle health and to increase the cattle population. However, the registration of new cattle health products or import of the same requires to go through various tests and certifications, before being allowed to enter the market.
Competitive Landscape
The cattle health market includes the major players such as Bayer AG, Boehringer Ingelheim, Ceva Sante Animale, Elanco Animal Health, IDVet, Merck & Co, Inc., Virbac, and Zoetis Inc., amongst others. Few of the companies such as Elanco, Ceva, Zoetis Inc., etc. are dominating the market and there are some local players which are holding a substantial share.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Expenditure in the Cattle Health Sector
4.2.2 Increasing Initiatives by Government and Animal Welfare Associations
4.2.3 Advanced Technology Leading to Innovations in the Cattle Health Sector
4.3 Market Restraints
4.3.1 Lack of Infrastructure and Funding
4.3.2 Increasing Costs of Animal Testing and Veterinary Services
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 By Therapeutics
5.1.1.1 Vaccine
5.1.1.2 Parasiticide
5.1.1.3 Anti-infective
5.1.1.4 Medical Feed Additive
5.1.1.5 Other Therapeutics
5.1.2 By Diagnostics
5.1.2.1 Immunodiagnostic Test
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zoetis Inc.
6.1.2 Merck & Co, Inc.
6.1.3 IDVet
6.1.4 Elanco Animal Health
6.1.5 Bayer AG
6.1.6 Ceva Sante Animale
6.1.7 Virbac
6.1.8 Boehringer Ingelheim
6.1.9 Idexx Laboratories
7 MARKET OPPORTUNITIES AND FUTURE TRENDS